Related Experiment Video
Updated: Jun 1, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
Published on: March 17, 2016
Circular RNA-centered regulatory networks in breast cancer: From ceRNA crosstalk to immune microenvironment
1Department of Thyroid and Breast Surgery, Chengdu Xinhua Hospital, Chengdu, China.
Abstract:
Circular RNAs (circRNAs) have emerged as a pervasive and functionally diverse class of regulatory molecules in breast cancer. While early studies predominantly described circRNAs as competing endogenous RNAs that modulate gene expression through microRNA sequestration, accumulating evidence indicates that this paradigm captures only a limited aspect of circRNA biology. Recent advances reveal that circRNAs function as central organizers of multilayered regulatory networks, integrating post-transcriptional control, RNA-protein interactions, noncanonical translation, metabolic adaptation, and immune microenvironment remodeling. In this review, we synthesize recent findings to propose a circRNA-centered network framework in breast cancer, highlighting how circRNAs orchestrate tumor progression, invasion, immune escape, and therapy resistance. We discuss key functional modules, including ceRNA crosstalk, RNA-binding protein scaffolding, circRNA-encoded peptides, ferroptosis and epitranscriptomic regulation, as well as immune checkpoint signaling and tumor-associated macrophage polarization. Importantly, we emphasize network-level convergence on shared signaling hubs such as PI3K/AKT, YAP/TAZ, STAT3, and cytokine-driven immune pathways, which link tumor-intrinsic plasticity to extrinsic immune suppression. Finally, we explore the translational implications of circRNA-centered networks as biomarkers and therapeutic targets, and outline future directions for integrating single-cell, spatial, and real-world clinical data. Collectively, this review reframes circRNAs from isolated regulators to central nodes of systems-level reprogramming in breast cancer, providing a conceptual foundation for network-informed precision oncology.
Insights
Circular RNAs (circRNAs) are key regulators in breast cancer, orchestrating complex networks that drive tumor progression and therapy resistance. Understanding these circRNA-centered networks offers new avenues for precision oncology.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Circular RNAs (circRNAs) are increasingly recognized as crucial regulatory molecules in breast cancer.
- Their roles extend beyond microRNA sequestration to complex network organization.
Purpose of the Study:
- To synthesize recent findings on circRNAs in breast cancer.
- To propose a circRNA-centered network framework for understanding breast cancer biology.
- To highlight the translational potential of circRNAs.
Main Methods:
- Review of recent scientific literature on circRNAs in breast cancer.
- Synthesis of data on circRNA functions including post-transcriptional control, RNA-protein interactions, translation, metabolism, and immune modulation.
- Analysis of network-level convergence on signaling hubs.
Main Results:
- CircRNAs act as central organizers of multilayered regulatory networks in breast cancer.
- These networks integrate diverse biological processes, influencing tumor progression, invasion, immune escape, and therapy resistance.
- CircRNAs converge on key signaling pathways like PI3K/AKT, YAP/TAZ, and STAT3, linking tumor plasticity to immune suppression.
Conclusions:
- CircRNAs are central nodes in systems-level reprogramming of breast cancer.
- CircRNA-centered networks provide a framework for understanding breast cancer complexity.
- CircRNAs hold translational potential as biomarkers and therapeutic targets for precision oncology.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Nucleolus
The Tumor Microenvironment
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...